# Nashat Y Gabrail MD – FDA Inspection, Jan 23, 2020

Source: https://www.keypedia.com/records/fda_inspections/nashat-y-gabrail-md/a9cf3ef1-bb98-4125-9258-ea5fe9255e97
Source feed: FDA_Inspections

> FDA inspection 1116861 of Nashat Y Gabrail MD, January 23, 2020. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1116861
- Company Name: Nashat Y Gabrail MD
- Inspection Date: 2020-01-23
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1313094 - 2026-04-15
- [FDA Inspection 911090 - 2015-01-21](https://www.keypedia.com/records/fda_inspections/nashat-y-gabrail-md/9d9e4bc8-afe6-4300-b114-0ba9365acf62)
- [FDA Inspection 634783 - 2009-12-17](https://www.keypedia.com/records/fda_inspections/nashat-y-gabrail-md/2bce4786-8147-4ea0-8277-7d1c254bd695)

Company: https://www.keypedia.com/companies/nashat-y-gabrail-md/b9479e97-f159-4b20-9f2d-4065f6f89143

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c